TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling

Nat Cell Biol. 2010 Mar;12(3):224-34. doi: 10.1038/ncb2022. Epub 2010 Feb 7.

Abstract

Parathyroid hormone (PTH) regulates calcium homeostasis and bone metabolism by activating PTH type I receptor (PTH1R). Here we show that transforming growth factor (TGF)-beta type II receptor (TbetaRII) forms an endocytic complex with PTH1R in response to PTH and regulates signalling by PTH and TGF-beta. TbetaRII directly phosphorylates the PTH1R cytoplasmic domain, which modulates PTH-induced endocytosis of the PTH1R-TbetaRII complex. Deletion of TbetaRII in osteoblasts increases the cell-surface expression of PTH1R and augments PTH signalling. Conditional knockout of TbetaRII in osteoblasts in mice results in a high bone mass with increased trabecular bone and decreased cortical bone, similar to the bone phenotype in mice expressing a constitutively active PTH1R. Disruption of PTH signalling by injection of PTH(7-34) or ablation of PTH1R rescues the bone phenotype of TbetaRII knockout mice. These studies reveal a previously unrecognized function for TbetaRII and a mechanism for integration of PTH and local growth factor at the membrane receptor level.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Arrestins / genetics
  • Arrestins / metabolism
  • Bone Density / genetics
  • Bone Remodeling / drug effects
  • Bone Remodeling / physiology*
  • Cell Count
  • Cells, Cultured
  • Collagen Type I / blood
  • Cyclic AMP / metabolism
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Endocytosis / drug effects
  • Endocytosis / genetics
  • Gene Expression / genetics
  • Humans
  • Leg Bones / drug effects
  • Leg Bones / pathology
  • Male
  • Mice
  • Mice, Knockout
  • Mutation / physiology
  • Osteoblasts / metabolism
  • Osteoblasts / pathology
  • Osteocalcin / blood
  • Osteoclasts / pathology
  • Parathyroid Hormone / antagonists & inhibitors
  • Parathyroid Hormone / metabolism
  • Parathyroid Hormone / pharmacology
  • Peptide Fragments / pharmacology
  • Peptides / blood
  • Phosphorylation / drug effects
  • Phosphorylation / physiology
  • Protein Binding / drug effects
  • Protein Binding / physiology
  • Protein Interaction Domains and Motifs / physiology
  • Protein Multimerization / drug effects
  • Protein Multimerization / physiology
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • RANK Ligand / metabolism
  • RNA, Small Interfering / genetics
  • Receptor, Parathyroid Hormone, Type 1 / genetics
  • Receptor, Parathyroid Hormone, Type 1 / metabolism*
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / genetics
  • Receptors, Transforming Growth Factor beta / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Smad Proteins / metabolism
  • beta-Arrestins

Substances

  • Arrestins
  • Collagen Type I
  • Cyclic AMP Response Element-Binding Protein
  • Parathyroid Hormone
  • Peptide Fragments
  • Peptides
  • RANK Ligand
  • RNA, Small Interfering
  • Receptor, Parathyroid Hormone, Type 1
  • Receptors, Transforming Growth Factor beta
  • Smad Proteins
  • Tnfsf11 protein, mouse
  • beta-Arrestins
  • collagen type I trimeric cross-linked peptide
  • parathyroid hormone (7-34)
  • Osteocalcin
  • Cyclic AMP
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II